FOXP3 and gastric cancer: A total of 14 articles, including 1,486 patients with gastric cancer, researched the clinical outcome of patients with high density of FOXP3+ TILs [6–8, 12, 14, 16, 17, 21, 23, 25, 31–33, 35].